A Post-Market Clinical Follow-up Investigation to Verify Performance and Safety of Viiral®Nasal Spray in Subjects With Dry Nose Symptoms
Not Applicable
Completed
- Conditions
- Rhinitis Sicca
- Interventions
- Device: Isotonic Saline Nasal SprayDevice: Sialic acid nasal spray
- First Posted Date
- 2022-03-03
- Last Posted Date
- 2022-10-13
- Lead Sponsor
- Viiral Nordic AB
- Target Recruit Count
- 84
- Registration Number
- NCT05264350
- Locations
- 🇸🇪
Universitetssjukhuset, Avdelning för kliniska prövningar, Örebro, Region Örebro, Sweden
🇸🇪Cordinator Medical Service AB, Linköping, Region Östergötland, Sweden
© Copyright 2025. All Rights Reserved by MedPath